Evaluation of Quality of Life in Patients on Different Treatment Modalities for Primary Glaucoma in a Tertiary Care Teaching Hospital- A Prospective Observational Study

Introduction: Glaucoma, causes irreversible vision loss, involves optic nerve damage due to increased aqueous outflow resistance in primary open-angle glaucoma (POAG) or iris blockage in primary-angle closure glaucoma (PACG). Objective: This study evaluates different treatment patterns and their eff...

Full description

Saved in:
Bibliographic Details
Main Authors: Hirva Santoki, Nishant B. Prajapati, Reema Raval, Kintu Shah, Hemant Tiwari, Shikha V. Sood
Format: Article
Language:English
Published: Indian Association of Preventive and Social Medicine 2025-03-01
Series:Healthline
Subjects:
Online Access:https://www.healthlinejournal.org/index_pdf/565.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Glaucoma, causes irreversible vision loss, involves optic nerve damage due to increased aqueous outflow resistance in primary open-angle glaucoma (POAG) or iris blockage in primary-angle closure glaucoma (PACG). Objective: This study evaluates different treatment patterns and their effectiveness in primary glaucoma using the NEI VFQ-25. Method: A 2-month prospective observational study included patients with primary glaucoma, excluding those with secondary glaucoma or other ocular conditions. The sample size was determined based on study duration. Treatment groups received medical, laser, or surgical interventions, alone or combined. NEI VFQ-25 was administered at baseline and one month. Results: Among 100 patients, mean age 56.7 years, equally divided between POAG and PACG, QoL improved significantly across all treatment groups, greatest in medical treatment alone, multimodal treatment, least. One-way ANOVA showed difference in treatment approach on outcomes. Conclusion: Using NEI-VFQ-25, study assessed QoL in glaucoma patients across six treatment groups, finding highest QoLwith medical therapy alone and lowest with combined treatments.
ISSN:2229-337X
2320-1525